Temmler Revenue and Competitors
Estimated Revenue & Valuation
- Temmler's estimated annual revenue is currently $13.7M per year.
- Temmler's estimated revenue per employee is $201,000
Employee Data
- Temmler has 68 Employees.
- Temmler grew their employee count by 6% last year.
Temmler's People
| Name | Title | Email/Phone |
|---|
Temmler Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Temmler?
Hormosan was founded in Germany over 50 years ago and ever since has developed successfully into a mid-sized pharmaceutical company. Today we market a large portfolio spanning from innovative medicines to generics and we focus on three core therapeutic areas: Rare diseases in neurology Pain therapy for chronic pain and headaches Sexual health with focus on oral contraceptives, erectile dysfunction and HIV With our innovative medicines we address so far unmet needs of our patients. Specific formulations or dosage forms of our specialty-like medications enhance patient benefits and compliance. And with our generics we provide high quality therapeutic options with attractive pricing. 2008 Hormosan was acquired by the international pharmaceutical LUPIN Group. Being embedded in this global network also continuously drives our competitiveness which is the fundament for us to provide long-term attractive therapeutic options to patients in the German market.
keywords:N/A
N/A
Total Funding
68
Number of Employees
$13.7M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Temmler News
It was the Nazis who started the trend with the development of Pervitin in 1938 by the Temmler pharmaceutical company, marketing it as a...
Pervitin, methamphetamine hydrochloride, developed by chemists Hauschild and Dobke from the German pharmaceutical company Temmler,...
Other Companies in Frankfurt
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.3M | 68 | 39% | N/A |
#2 | $16.8M | 69 | 6% | N/A |
#3 | $13.4M | 71 | 31% | N/A |
#4 | N/A | 72 | 7% | N/A |
#5 | $14.5M | 73 | 40% | N/A |